JP2022543060A5 - - Google Patents
Info
- Publication number
- JP2022543060A5 JP2022543060A5 JP2022506472A JP2022506472A JP2022543060A5 JP 2022543060 A5 JP2022543060 A5 JP 2022543060A5 JP 2022506472 A JP2022506472 A JP 2022506472A JP 2022506472 A JP2022506472 A JP 2022506472A JP 2022543060 A5 JP2022543060 A5 JP 2022543060A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- amino acid
- mage
- acid sequence
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880508P | 2019-07-30 | 2019-07-30 | |
| US62/880,508 | 2019-07-30 | ||
| PCT/IB2020/057177 WO2021019477A1 (en) | 2019-07-30 | 2020-07-29 | T cell receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543060A JP2022543060A (ja) | 2022-10-07 |
| JP2022543060A5 true JP2022543060A5 (https=) | 2023-08-08 |
| JP7669347B2 JP7669347B2 (ja) | 2025-04-28 |
Family
ID=74229599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506472A Active JP7669347B2 (ja) | 2019-07-30 | 2020-07-29 | Ｔ細胞受容体及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220275046A1 (https=) |
| EP (1) | EP4004218A4 (https=) |
| JP (1) | JP7669347B2 (https=) |
| KR (1) | KR20220038776A (https=) |
| CN (1) | CN114364806A (https=) |
| AU (1) | AU2020322247A1 (https=) |
| BR (1) | BR112022001697A2 (https=) |
| CA (1) | CA3146303A1 (https=) |
| IL (1) | IL290228A (https=) |
| MX (1) | MX2022001206A (https=) |
| TW (1) | TWI869426B (https=) |
| WO (1) | WO2021019477A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| KR20220087431A (ko) | 2019-07-30 | 2022-06-24 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7157091B1 (en) * | 1999-06-18 | 2007-01-02 | Ludwig Institute For Cancer Research | MAGE-A1 peptides presented by HLA class II molecules |
| KR101363928B1 (ko) * | 2007-06-11 | 2014-02-19 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 특이적 유전자 발현 방법 |
| WO2012054825A1 (en) * | 2010-10-22 | 2012-04-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-mage-a3 t cell receptors and related materials and methods of use |
| CA3051222C (en) * | 2013-06-10 | 2023-01-24 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for reducing immunosupression by tumor cells |
| WO2017185169A1 (en) * | 2016-04-27 | 2017-11-02 | University Health Network (Uhn) | Pept1de-hla complexes and methods of producing same |
| GB2573069A (en) * | 2016-12-16 | 2019-10-23 | Twist Bioscience Corp | Variant libraries of the immunological synapse and synthesis thereof |
| US10738100B2 (en) * | 2017-01-27 | 2020-08-11 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| CA3073055A1 (en) * | 2017-09-04 | 2019-03-07 | Agenus Inc. | T cell receptors that bind to mixed lineage leukemia (mll)-specific phosphopeptides and methods of use thereof |
| KR20260026092A (ko) * | 2017-09-19 | 2026-02-25 | 메사추세츠 인스티튜트 오브 테크놀로지 | 키메라 항원 수용체 t 세포 요법을 위한 조성물 및 그의 용도 |
| WO2019222275A2 (en) * | 2018-05-14 | 2019-11-21 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using inducible fusion proteins |
| GB201814362D0 (en) * | 2018-09-04 | 2018-10-17 | Treos Bio Zrt | Composition and process for preparing vaccine |
| WO2020154617A1 (en) * | 2019-01-25 | 2020-07-30 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting mutant ras |
-
2020
- 2020-07-29 TW TW109125670A patent/TWI869426B/zh active
- 2020-07-29 WO PCT/IB2020/057177 patent/WO2021019477A1/en not_active Ceased
- 2020-07-29 CN CN202080064113.1A patent/CN114364806A/zh active Pending
- 2020-07-29 BR BR112022001697A patent/BR112022001697A2/pt unknown
- 2020-07-29 KR KR1020227006954A patent/KR20220038776A/ko active Pending
- 2020-07-29 AU AU2020322247A patent/AU2020322247A1/en active Pending
- 2020-07-29 CA CA3146303A patent/CA3146303A1/en active Pending
- 2020-07-29 MX MX2022001206A patent/MX2022001206A/es unknown
- 2020-07-29 JP JP2022506472A patent/JP7669347B2/ja active Active
- 2020-07-29 US US17/631,830 patent/US20220275046A1/en active Pending
- 2020-07-29 EP EP20847664.8A patent/EP4004218A4/en active Pending
-
2022
- 2022-01-30 IL IL290228A patent/IL290228A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (https=) | ||
| JP2022523554A5 (https=) | ||
| JP2022524994A5 (https=) | ||
| JP2022523552A5 (https=) | ||
| Lowe et al. | Novel TCR-based biologics: mobilising T cells to warm ‘cold’tumours | |
| JP2022524993A5 (https=) | ||
| JP2022523971A5 (https=) | ||
| JP2022523553A5 (https=) | ||
| Kershaw et al. | Gene-engineered T cells for cancer therapy | |
| JP2022169543A (ja) | 改善された養子ｔ細胞療法 | |
| US20190117692A1 (en) | Engager cells for immunotherapy | |
| RU2018147423A (ru) | Анти-PD-L1 и IL-2 цитокины | |
| JP2022524992A5 (https=) | ||
| AU2019243448A1 (en) | Guidance and navigation control proteins and method of making and using thereof | |
| JP2022543059A5 (https=) | ||
| JP2021512637A5 (https=) | ||
| WO2021223720A1 (zh) | 人源化cd19抗体及其应用 | |
| JP2020533962A5 (https=) | ||
| IL301995A (en) | Cells comprising t cell-antigen couplers and uses thereof | |
| CA3117079A1 (en) | Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof | |
| JP2023542528A5 (https=) | ||
| JP2022543060A5 (https=) | ||
| JP2022543058A5 (https=) | ||
| KR20250158012A (ko) | 키메라 항원 수용체 | |
| JP2022547809A5 (https=) |